What is Amani Therapeutics worth?
$44.5Mlast known valuation
Amani Therapeutics last raised $31.1M in its Early Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Amani Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $31.1M | ▮ | ▮ |
How Amani Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Amani Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Amani Therapeutics worth?
- Amani Therapeutics's last known valuation is $44.5M.
- How much has Amani Therapeutics raised?
- Amani Therapeutics has raised $31.1M in total funding across 1 recorded rounds.
- When did Amani Therapeutics last raise?
- Amani Therapeutics last raised in Nov 2025 (Early Stage VC), raising $31.1M.